首页> 外文OA文献 >Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer

【2h】

Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer

机译：系统结构改性多元前列腺癌药物候选Galeterone生产新的雄激素受体下调剂作为治疗晚期前列腺癌的方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Puranik Purushottamachar; Abhijit M. Godbole; Lalji K. Gediya; Marlena S. Martin; Tadas S. Vasaitis; Andrew K. Kwegyir-Afful; Senthilmurugan Ramalingam; Zeynep Ates-Alagoz; Vincent C. O. Njar;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer [J] . Purushottamachar P., Godbole A.M., Gediya L.K., Journal of Medicinal Chemistry . 2013,第12期

机译：多靶点前列腺癌候选药物加勒酮的系统结构修饰，以产生新型雄激素受体下调剂，作为晚期前列腺癌的治疗方法
2. Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer [J] . Antonarakis Emmanuel S., Chandhasin Chandtip, Osbourne Erica, The oncologist . 2016,第12期

机译：靶向雄激素受体的N-末端结构域：一种治疗晚期前列腺癌的新方法
3. Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer [J] . Emmanuel S. Antonarakis, Chandtip Chandhasin, Erica Osbourne, The oncologist . 2016,第12期

机译：靶向雄激素受体的N-末端结构域：一种治疗晚期前列腺癌的新方法
4. Proteome-wide drug dose-response of prostate cancer cell lines exposed to androgen receptor antagonist by microflow-LC SWATH MS analysis [C] . L.C. Gillet, S. Amon, Y. Uchida, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：通过Microflow-LC SWATH MS分析将前列腺癌细胞拮抗剂暴露于雄激素受体拮抗剂的前列腺癌细胞响应
5. Therapeutic Targeting of Stat5a/b in Advanced Prostate Cancer: Inhibition of Stat5a/b Suppresses Growth of Prostate Cancer through Mechanisms Dependent and Independent of Androgen Receptor. [D] . Hoang, David Timothy. 2016

机译：Stat5a / b在晚期前列腺癌中的治疗靶点：Stat5a / b的抑制作用通过依赖于雄激素受体的机制来抑制前列腺癌的生长。
6. Systematic Structure Modifications of Multi-target Prostate Cancer Drug Candidate Galeterone to Produce Novel Androgen Receptor Down-regulating Agents as an Approach to Treatment of Advanced Prostate Cancer [O] . Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya, -1

机译：系统结构修饰的多靶点前列腺癌候选药物加勒泰酮生产新型雄激素受体下调剂作为晚期前列腺癌的治疗方法
7. Novel Approach: Androgen Receptor Down-Regulating Agents for the Treatment of All Stages of Prostate Cancer Disease [O] . Puranik Purushottamachar 2012

机译：新方法：雄激素受体下调剂治疗前列腺癌病的所有阶段
8. Molecular Determinants of Prostate Cancer Progression Across Race- Ethnicity. Project A - The Human 5RD5A2 Gene and Prostate Cancer Progression. Project B - Androgen Receptor (AR) Signaling in Prostate Cancer Progression. Project C - Cellular and Molecular Markers of Prostate Cancer Progression Core - Epidemiology Core [R] . Ross, R. R. , Reichardt, J. , Coetzee, G. A. , 2002

机译：跨越种族的前列腺癌进展的分子决定因素。项目a - 人类5RD5a2基因和前列腺癌进展。项目B - 雄激素受体（aR）在前列腺癌进展中的信号传导。项目C - 前列腺癌进展核心的细胞和分子标记 - 流行病学核心

Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅